WCN24-847 SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL by Jonathan Barratt, Brad Rovin, Edward Murphy, Radko Komers, Hernán Trimarchi, Vlado Perkovic

Get full text

Is There a Role for Mammalian Target of Rapamycin Inhibition in Renal Failure due to Mesangioproliferative Nephrotic Syndrome? by Hernán Trimarchi, Mariano Forrester, Fernando Lombi, Vanesa Pomeranz, Romina Iriarte, María Soledad Raña, Pablo Young

Get full text

WCN24-1884 THROMBOTIC MICROANGIOPATHY, SYSTEMIC LUPUS ERYTHEMATOSUS, AND A VITAMIN B12 MUTATION: A CAUSE OF PRIMARY ATYPICAL HEMOLYTIC UREMIC SYNDROME? by Jose Heriberto Díaz Góngora, Hernan Trimarchi, Mariano Forrester, Sandra Liliana Borda, Mariana Ursino, Matias Monkowski, Mauro Lampo

Get full text

WCN24-2592 GENETIC DIAGNOSIS OF CHRONIC KIDNEY DISEASE: A SINGLE-CENTER STUDY by EUGENIA FLORES, Mariana Ursino, Mariano Forrester, Romina Iriarte, Fernando Lombi, Matias Monkowski, Jose Diaz, Liliana Borda, Hernán Trimarchi

Get full text

WCN24-1837 BEYOND: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL OF ZIGAKIBART IN ADULTS WITH IGA NEPHROPATHY by Hernán Trimarchi, Jonathan Barratt, Jai Radhakrishnan, Dana V. Rizk, Bess Sorensen, Jocelyn Leiske, Zeeshan Khawaja, Kirk Campbell, Vlado Perkovic

Get full text

WCN24-1921 NEPHROTIC SYNDROME SECONDARY AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS DUE TO PODOCYTE KANK-2 MUTATION by Sandra Liliana Borda Galindo, Mariana Ursino, Oscar Chávez, Mauro Lampo, Matías Monkowski, Fernando Lombi, Romina Iriarte, Mariano Forrester, Hernán Trimarchi

Get full text

WCN24-2606 KIDNEY RE-BIOPSY IN ADULTS WITH IGA NEPHROPATHY by Leonel Langellotti, Carolina Lozina, Oscar Chavez, Jimena Lodolo, Mariana Ursino, Liliana Borda, Mauro Lampo, Jose Diaz Gongora, Eugenia Flores, Matias Monkowski, Hernan Trimarchi

Get full text

WCN24-1674 NEFECON TREATMENT RESPONSE IN ASIAN AND WHITE PATIENT POPULATIONS WITH IMMUNOGLOBULIN A NEPHROPATHY: A 2YEAR ANALYSIS OF THE PHASE III NEFIGARD TRIAL by Jonathan Barratt, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Richard Lafayette

Get full text

WCN24-1774 eGFR DECLINE IN PATIENTS WITH IgAN TREATED WITH NEFECON OR PLACEBO: RESULTS FROM THE 2-YEAR NefIgArd PHASE 3 TRIAL by Richard Lafayette, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Jonathan Barratt

Get full text

WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL by Jonathan Barratt, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Richard Lafayette

Get full text

WCN24-1776 NEFECON EFFECT ON QUALITY OF LIFE IN PATIENTS WITH IgAN: SF-36 RESULTS FROM THE PHASE 3 NeFIgArd TRIAL by Jonathan Barratt, Jens Kristensen, Andrew Stone, Jürgen Floege, Vladimír Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Heather N. Reich, Brad H. Rovin, Richard Lafayette

Get full text

WCN24-1414 ORIGIN 3: PIVOTAL PHASE 3 STUDY EVALUATING EFFECT OF ATACICEPT VS PLACEBO ON PROTEINURIA AND RENAL FUNCTION PRESERVATION IN IGA NEPHROPATHY by Jonathan Barratt, Bart Maes, Rubeen Israni, Xuelian Wei, Jürgen Floege, Vivekanand Jha, Vladimir Tesar, Hong Zhang, Sean Barbour, Hitoshi Suzuki, Hernan Trimarchi, Celia Lin, Richard Lafayette

Get full text

WCN24-2582 EPIDEMIOLOGICAL PROFILE OF KDIGO STAGE III ACUTE KIDNEY INJURY WITH THE NEED FOR RENAL SUPPORT THERAPY IN THE INTENSIVE CARE UNIT: OUR EXPERIENCE by Leonel Langellotti, Carolina Lozina, Briant Gauna, Eugenia Flores, Jose Diaz Gongora, Liliana Borda, Mariana Ursino, Mauro Lampo, Matias Monkowski, Romina Iriarte, Mariano Forrester, Fernando Lombi, Hernan Trimarchi

Get full text

WCN24-2542 HEMODYNAMIC INESTABILITY IN DIALYSIS AS A PREDICTOR OF MORTALITY IN CRITICALLY ILL PATIENTS by Leonel Langellotti, Carolina Lozina, Briant Gauna, Eugenia Flores, Jose Diaz Gongora, Liliana Borda, Mariana Ursino, Mauro Lampo, Matias Monkowski, Romina Iriarte, Mariano Forrester, Fernando Lombi, Hernan Trimarchi

Get full text

WCN25-499 PATIENT BASELINE CHARACTERISTICS IN THE ONGOING PHASE 3 VISIONARY TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SIBEPRENLIMAB FOR IMMUNOGLOBULIN A NEPHROPATHY by Richard Lafayette, Hernan Trimarchi, Jonathan Barratt, Kevin Carroll, Vladimír Tesar, Hong Zhang, Yusuke Suzuki, Adrian Liew, Muh Geot Wong, Lokesh Shah, Jing Xia, Cecile Fajaro, Jeffrey Hafkin, Vlado Perkovic

Get full text

WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS) by Jonathon Barratt, Anant Desai, Alessia Fornoni, Lesley Inker, Irene de Lourdes Noronha, Alejandra Quevedo, Robert Shepherd, Alisha Smith, Hernan Trimarchi, Lucila Valente, Mona Wahba, Muh Geot Wong, Hiddo Lambers Heerspink

Get full text

Erratum to “Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1283-1287]... by Sean J. Barbour, Rosanna Coppo, Jonathan Barratt, Lee Er, Richard Lafayette, Hiddo J.L. Heerspink, Dana V. Rizk, Adrian Liew, Vivekanand Jha, Hong Zhang, Yusuke Suzuki, Hernan Trimarchi, Daniel C. Cattran

Get full text

Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts by Sean J. Barbour, Rosanna Coppo, Jonathan Barratt, Lee Er, Richard Lafayette, Hiddo J.L. Heerspink, Dana V. Rizk, Adrian Liew, Vivekanand Jha, Hong Zhang, Yusuke Suzuki, Hernan Trimarchi, Daniel C. Cattran

Get full text

Corrigendum to “Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy” [Volume 10, Issue 1, January 2025,... by Hiddo J.L. Heerspink, Meg Jardine, Donald E. Kohan, Richard A. Lafayette, Adeera Levin, Adrian Liew, Hong Zhang, Irene Noronha, Hernan Trimarchi, Fan Fan Hou, Ronny Renfurm, Todd Gray, Marianne Camargo, Jonathan Barratt

Get full text

Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy by Hiddo J.L. Heerspink, Meg Jardine, Donald E. Kohan, Richard A. Lafayette, Adeera Levin, Adrian Liew, Hong Zhang, Irene Noronha, Hernan Trimarchi, Fan Fan Hou, Ronny Renfurm, Todd Gray, Marianne Camargo, Jonathan Barratt

Get full text